TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 41 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,590,000 | -82.5% | 500,000 | -76.6% | 0.78% | -77.0% |
| Q1 2024 | $77,756,358 | +72.9% | 2,139,102 | -3.7% | 3.41% | +58.8% |
| Q4 2023 | $44,983,796 | -3.4% | 2,221,422 | -15.3% | 2.15% | -20.9% |
| Q3 2023 | $46,582,669 | +81.4% | 2,621,422 | +84.4% | 2.72% | +88.8% |
| Q2 2023 | $25,685,096 | +143657.2% | 1,421,422 | 0.0% | 1.44% | +22.3% |
| Q1 2023 | $17,867 | -29.8% | 1,421,422 | -18.1% | 1.18% | -30.9% |
| Q4 2022 | $25,456 | -99.9% | 1,736,422 | -11.9% | 1.70% | -27.8% |
| Q3 2022 | $33,751,000 | +23.3% | 1,971,422 | +5.1% | 2.36% | +14.0% |
| Q2 2022 | $27,375,000 | +18.3% | 1,875,000 | +36.3% | 2.07% | +16.5% |
| Q1 2022 | $23,144,000 | -26.7% | 1,375,982 | -1.9% | 1.78% | -5.4% |
| Q4 2021 | $31,575,000 | +1.4% | 1,403,331 | -2.9% | 1.88% | +48.5% |
| Q3 2021 | $31,136,000 | -29.0% | 1,444,831 | -4.6% | 1.26% | -15.2% |
| Q2 2021 | $43,884,000 | -20.6% | 1,514,269 | -11.7% | 1.49% | +21.1% |
| Q1 2021 | $55,251,000 | -21.0% | 1,714,269 | 0.0% | 1.23% | -26.1% |
| Q4 2020 | $69,965,000 | – | 1,714,269 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,254,797 | $61,285,382 | 6.24% |
| Ikarian Capital, LLC | 800,277 | $21,751,529 | 3.79% |
| TFG Asset Management GP Ltd | 500,000 | $13,590,000 | 3.39% |
| Paradigm Biocapital Advisors LP | 2,435,416 | $66,194,607 | 2.53% |
| Frazier Life Sciences Management, L.P. | 1,587,527 | $43,148,984 | 2.02% |
| Ghost Tree Capital, LLC | 235,000 | $6,387,300 | 2.00% |
| COWEN AND COMPANY, LLC | 2,197,385 | $59,724,924 | 1.64% |
| TCG Crossover Management, LLC | 556,317 | $15,120,696 | 1.58% |
| Sands Capital Ventures, LLC | 170,000 | $4,620,600 | 1.55% |
| BOONE CAPITAL MANAGEMENT LLC | 216,047 | $5,872,157 | 1.53% |